Skip to main content
Earnings Labs
AC

Actuate Therapeutics Inc (ACTU)

NASDAQ·Healthcare·Biotechnology

$0.31

-4.10%

Mkt Cap $8.88M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (1 analysts)

$21.00

Range $21.00 – $21.00

Implied Upside

+6596.4%

Consensus $21.00 vs current $0.31